Wells Pharmacy Products / Photo: Wells Pharmacy
A recent CNN article discussed a major recall issued for all sterile products produced by Wells Pharmacy Network. The FDA issued a recall announcement stating “concern over a lack of sterility assurance.” The Wells Pharmacy facilities are undergoing an expansion, and the FDA asked for a recall of all medications made during the construction period.
The voluntary recall includes all products prepared between February 22 and September 16, and includes injectable solutions of hormones progesterone, testosterone, and gonadotropin. Consumers in possession of affected products should not use them, and are instructed to contact the company for information on returning them.
